GlaxoSmithKline gets double target price lift from Barclays and Deutsche Bank on growth expectations

08:44 EDT 3 Jul 2018 | Proactive Investors

Analysts at both investment banks expected EPS growth for the FTSE 100 pharma group, while also expecting more clarity from GSK's new head of research and development

More From BioPortfolio on "GlaxoSmithKline gets double target price lift from Barclays and Deutsche Bank on growth expectations"